Opportunity Information: Apply for RFA DA 23 040

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), released this funding opportunity to create a Coordinating Center (CC) for its HIV/AIDS and Substance Use Cohorts Program. The underlying program consists of multiple longitudinal cohort studies focused on HIV/AIDS in the context of both injection and non-injection substance use. These cohorts collectively generate extensive data and bio-specimens and support a wide range of research, including basic immunology and virology, studies of HIV prevention and treatment, and investigations into common co-morbidities and co-infections seen when HIV and substance use intersect. The main idea behind the announcement is that, while the individual cohorts are already productive, NIDA believes a dedicated coordinating structure is necessary to fully unlock the value of these resources, reduce duplication, increase consistency, and make collaboration easier and faster across studies and with outside investigators.

The Coordinating Center is intended to function as the connective hub across the NIDA-funded cohorts and NIDA program staff. A central expectation is that the CC will help optimize collaborations not only among the cohort investigators themselves, but also between the cohort program and other researchers who are not directly funded through the cohort mechanism. In practical terms, the CC is meant to improve the efficiency and reach of investigator-initiated research by making it clearer what data and specimens exist, how they can be requested and used, and how multi-cohort questions can be organized and answered. The opportunity also emphasizes infrastructure-like responsibilities rather than running an independent clinical trial, which aligns with the funding mechanism and the explicit "Clinical Trial Not Allowed" designation.

A key deliverable described in the opportunity is establishing a virtual repository. This concept generally implies an organized, searchable, and well-governed system that helps researchers discover and request access to available cohort data and bio-specimens, while respecting the ethical, legal, and consent-related constraints that apply to sensitive HIV and substance use information. The repository function is paired with an organizing role for leadership and governance: the CC is expected to facilitate the work of the cohorts Steering Committee (SC). The SC includes representatives from the NIDA-funded cohorts and NIDA staff, and the CC would support its operations, coordination, and communication so the cohorts can align on shared priorities, policies, and collaborative activities.

Administratively, this opportunity is offered as a cooperative agreement (U24), which usually means NIH/NIDA anticipates substantial programmatic involvement during the award period compared to a standard research grant. The Funding Opportunity Number is RFA-DA-23-040, and the listed CFDA number is 93.279. The activity area is categorized under Education and Health, reflecting that the award supports research-enabling coordination, data infrastructure, and collaboration rather than direct service delivery. The original closing date shown is 2022-08-10, and the posting (creation) date is 2022-04-26.

Eligibility is broad and includes many types of U.S.-based organizations and governments. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The announcement also explicitly highlights additional eligible categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

At the same time, there are important limits related to non-U.S. participation. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply as the primary applicant. Non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which typically means a U.S. applicant may include certain foreign elements in the project if justified and permissible under NIH policy, even though a foreign organization cannot serve as the applicant institution.

Overall, the opportunity is designed to strengthen and unify a network of HIV/AIDS and substance use cohorts by providing centralized coordination, governance support, and an access-oriented virtual repository. NIDA is essentially investing in shared infrastructure so that the cohorts' accumulated longitudinal data and bio-specimens can be used more strategically, rapidly, and collaboratively to answer emerging questions about HIV pathogenesis, prevention, and treatment in the real-world context of substance use, including the complex co-infections and co-morbidities that often accompany it.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2022-04-26.
  • Applicants must submit their applications by 2022-08-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 23 040

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for HIV and AIDS support

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed)

Previous opportunity: Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 23 040

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 23 040) also looked into and applied for these:

Funding Opportunity
Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) Apply for RFA DA 23 012

Funding Number: RFA DA 23 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) Apply for PAR 22 182

Funding Number: PAR 22 182
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) Apply for PAR 22 183

Funding Number: PAR 22 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional) Apply for RFA CA 22 027

Funding Number: RFA CA 22 027
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed) Apply for RFA DA 23 027

Funding Number: RFA DA 23 027
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required) Apply for RFA DA 23 008

Funding Number: RFA DA 23 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 22 056

Funding Number: RFA NS 22 056
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 22 187

Funding Number: PAR 22 187
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 22 188

Funding Number: PAR 22 188
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) Apply for RFA AI 22 038

Funding Number: RFA AI 22 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed) Apply for RFA DA 23 015

Funding Number: RFA DA 23 015
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAR 22 181

Funding Number: PAR 22 181
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 23 020

Funding Number: RFA DA 23 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 23 019

Funding Number: RFA DA 23 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PAR 22 165

Funding Number: PAR 22 165
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Apply for PAR 22 164

Funding Number: PAR 22 164
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Apply for PAR 22 198

Funding Number: PAR 22 198
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 026

Funding Number: RFA CA 22 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $5,500,000
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) Apply for PAR 22 199

Funding Number: PAR 22 199
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 052

Funding Number: RFA DA 23 052
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 040", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: